Healthcare costs of the progression of chronic kidney disease and different dialysis techniques estimated through administrative database analysis
Tóm tắt
Chronic kidney disease (CKD) progression is associated with
significant comorbidities and costs. In Italy, limited evidence of healthcare resource consumption and costs is available. We therefore aimed to investigate the direct healthcare costs in charge to the Lombardy Regional Health Service (RHS) for the treatment of CKD patients in the first year after starting hemodialysis and in the 2 years prior to dialysis. Citizens resident in the Lombardy Region (Italy) who initiated dialysis in the year 2011 (Jan 1 to Dec 31) were selected and data were extracted from Lombardy Regional databases on their direct healthcare costs in the first year after starting dialysis and in the 2 years prior to it was analyzed. Drugs, hospitalizations, diagnostic procedures and outpatient costs covered by RHS were estimated. Patients treated for acute kidney injury, or who died or stopped dialysis during the observational period were excluded. From the regional population (>9,700,000 inhabitants), 1067 patients (34.3 % females) initiating dialysis were identified, of whom 82 % underwent only hemodialysis (HD), 13 % only peritoneal dialysis (PD) and the remaining 5 % both treatments. Direct healthcare costs/patient were € 5239, € 12,303 and € 38,821 (€ 40,132 for HD vs. € 30,444 for PD patients) for the periods 24–12 months pre-dialysis, 12–0 months pre-dialysis, and in the first year of dialysis, respectively. This study highlights a significant economic burden related to CKD and an increase in direct healthcare costs associated with the start of dialysis, pointing to the importance of prevention programs and early diagnosis.
Tài liệu tham khảo
Centers for Disease Control and Prevention (CDC) (2015) Chronic Kidney Disease Initiative—Protecting Kidney Health. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention. Available at http://www.cdc.gov/diabetes/projects/pdfs/ckd_summary.pdf. Accessed September, 9th 2015
Couser WG, Remuzzi G, Mendis S, Tonelli M (2011) The contribution of chronic kidney disease to the global burden of major non communicable diseases. Kidney Int 80(12):1258–1270. doi:10.1038/ki.2011.368 Epub 2011 Oct 12
Levey AS, Astor BC, Stevens LA et al (2010) Chronic kidney disease, diabetes, and hypertension: what’s in a name? Kidney Int 78:19–22
Keith DS, Nichols GA, Gullion CM et al (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164:659–663
Wen CP, Cheng TY, Tsai MK et al (2008) All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462,293 adults in Taiwan. Lancet 371:2173–2182
Eriksen BO, Ingebretsen OC (2006) The progression of chronic kidney disease: a 10-year population-based study of the effects of gender and age. Kidney Int 69:375–382
Levey AS, Atkins R, Coresh J et al (2007) Chronic kidney disease as a global public health problem: approaches and initiatives—a position statement from Kidney Disease Improving Global Outcomes. Kidney Int 72:247–259
Pontoriero G, Pozzoni P, Vecchio LD et al (2007) International Study of Health Care Organization and Financing for renal replacement therapy in Italy: an evolving reality. Int J Health Care Finance Econ 7:201–215
Roggeri DP, Roggeri A, and Salomone M (2014) Chronic kidney disease: evolution of healthcare costs and resource consumption from predialysis to dialysis in Piedmont Region, Italy. Adv Nephrol 2014, Article ID 680737, 6 pages. doi:10.1155/2014/680737
Cicchetti A, Ruggeri M, Codella P, Ridolfi A (2011) I costi socio-sanitari dell’insufficienza renale cronica. Farmeconomia e Percorsi Terapeutici 12(1):21–28
International Classification of Diseases (ICD) (1978) 9th Revision, Basic Tabulation List with Alphabetic Index. World Health Organization, Geneva
World Health Organization Collaborating Centre for Drug Statistics and Methodology (2015). Available at http://www.whocc.no/atc_ddd_index/. Accessed September, 9th 2015
Zoccali C, Kramer A, Jager KJ (2010) Chronic kidney disease and end-stage renal disease—a review produced to contribute to the report ‘the status of health in the European union: towards a healthier Europe’. NDT Plus 3(213–312):224
Gorodetskaya I, Zenios S, McCulloch CE et al (2005) Health-related quality of life and estimates of utility in chronic kidney disease. Kidney Int 68:2801–2808
Kimmel PL, Patel SS (2006) Quality of life in patients with chronic kidney disease: focus on end-stage renal disease treated with hemodialysis. Semin Nephrol 26:68–79
Schieppati A, Remuzzi G (2005) Chronic renal diseases as a public health problem: epidemiology, social, and economic implications. Kidney Int 68(Supplement 98):S7–S10
Global Burden of Disease Study (2013) Collaborators (2015) Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386(9995):743–800. doi:10.1016/S0140-6736(15)60692-4
St. Peter WL, Khan SS, Ebben JP et al (2004) Chronic kidney disease: the distribution of health care dollars. Kidney Int 66:313–321
Salonen T, Reina T, Oksa H et al (2003) Cost analysis of renal replacement therapies in Finland. Am J Kidney Dis 42(6):1228–1238
Coentrão LA, Araújo CS, Ribeiro CA et al (2013) Cost analysis of hemodialysis and peritoneal dialysis access in incident dialysis patients. Perit Dial Int 33(6):662–670
Karopadi AN, Mason G, Rettore E et al (2013) Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant 28(10):2553–2569
Liu FX, Quock TP, Burkart J et al (2013) Economic evaluations of peritoneal dialysis and hemodialysis: 2004–2012. F1000Research 2:273
Just PM, Riella MC, Tschosik EA et al (2008) Economic evaluations of dialysis treatment modalities. Health Policy 86(2–3):163–180
Li B, Cairns JA, Fotheringham J et al (2015) Understanding cost of care for patients on renal replacement therapy: looking beyond fixed tariffs. Nephrol Dial Transplant 30(10):1726–1734. doi:10.1093/ndt/gfv224
Haut ER, Pronovost PJ, Schneider EB (2012) Limitations of administrative databases. JAMA 307(24):2589–2590
Schneeweiss S, Avorn J (2005) A review of uses of healthcare utilization databases for epidemiologic research on therapeutics. J Clin Epidemiol 58(4):323–337
Harpe SE (2009) Using secondary data sources for pharmacoepidemiology and outcomes research. Pharmacotherapy 29(2):138–153
National Kidney Foundation (2002) K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 39(suppl 1):S1–S266